NEWSWIRE
Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, New Hampshire, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Utah, West Virginia and Wyoming. Changes to Joint Commission accredita- tion requirements for the affected deemed programs are under review, and accred- ited organizations will be notified of any changes via Joint Commission Perspectives. In the interim, for any findings related to the regulatory requirements for COVID- 19 staff vaccination, The Joint Commis- sion will score Leadership (LD) Standard LD.04.01.01, element of performance (EP) 2: The organization provides care, treatment, and services in accordance with licensure requirements, laws, and rules and regula- tions, along with the applicable Medicare conditions of participation/conditions for coverage.
The cost benefits of primary prevention of from emerging infectious disease pandemics Two years after COVID-19 emerged, researchers have provided three cost- effective actions to help decision-makers prevent future pandemics by stopping “spillover” of diseases from animals into humans: better surveillance of pathogens, better management of wildlife trade and hunting, and reduced deforestation, accord- ing to a report from Harvard
T.H.Chan School of Public Health.
The annual costs of these “primary pan- demic prevention” actions (~$20 billion) are less than 5% of the lowest estimated value of lives lost from emerging infectious diseases every year, less than 10% of the economic costs, and provide substantial co-benefits. The research by 20 experts, published in Science Advances, was led by Dr. Aaron Bernstein, director of the Center for Climate, Health, and the Global Envi- ronment at Harvard T.H. Chan School of Public Health. Today, 3.3 million people are expected to die each year from viral zoonotic diseases. The estimated value of these lost lives is - at a minimum - $350 billion with an additional $212 billion in direct economic losses. This amount is based on lives lost from every new viral zoonosis—diseases that “spill- over” into humans—since 1918 that killed at least 10 people. According to the authors, preventing spillover at the source is rarely addressed when policymakers and multilateral orga- nizations discuss pandemic risks—despite the fundamental role spillovers play in spreading emerging infections. To address this, the paper recommends revising the
8
World Health Organization’s “phases of infectious disease emergence” to include a specific phase for spillover. They further coin a new paradigm—“primary pandemic prevention”to define actions that stamp out new diseases before they spread, rather than actions that address disease outbreaks after they occur.
Primary prevention actions and recommenda- tions include: •Better surveillance of pathogens that may spill from animals to people
•A global viral discovery project should be developed to target where prevention activities should be focused geographi- cally. This library can help quickly iden- tify pathogens when they emerge and accelerate our ability to develop tests and vaccines rapidly and deploy them widely. •More well-trained veterinarians are needed, especially in spillover hotspots, to monitor for emerging diseases and pre- vent spillover from wildlife or livestock into people.
•Better management of wildlife trade and hunting
Inadequate monitoring and surveillance of the wildlife trade enables zoonotic dis- ease emergence. Deforestation, particularly in the tropics, brings people into contact with animals as they enter forests to clear them for agriculture or timber, build roads, or work in mines, that facilitate contact between people and viral reservoir hosts.
Alliance created to promote blood supply The AABB (Association for the Advance- ment of Blood & Biotherapies) recently launched the Alliance for a Strong Blood Supply to help ensure sufficient blood is available for all patients during the pan- demic and beyond.
In explaining the rationale behind the new organization, Debra BenAvram, CEO of AABB, said, “The COVID-19 pandemic has exacerbated chronic challenges that have impacted the nation’s blood for some time.”
The initial 17 organizations involved in the alliance represent hospitals, blood banks, as well as more than 200,000 phy- sicians who provide blood to patients in need.
AABB said that many blood banks are operating with less than a one-day supply on hand, which is below the goal of at least a three-day supply. “As a result, hospitals have been forced to delay life-saving blood transfusions and postpone nonessential surgeries. Without immediate action to strengthen the blood supply, the effect on patient care could be disastrous,” the AABB said.
March 2022 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
The alliance plans to launch advocacy and communications campaigns to discuss “the importance of blood donation, the value of blood transfusions and why a robust blood supply is critical to patient care,” the AABB said. The organization’s members also plan to share best practices on stewardship of the blood supply.
In addition to AABB, the initial members
of the Alliance are: the Alliance for Commu- nity Transfusion Services, America’s Blood Centers, American College of Emergency Physicians, American College of Surgeons, ADRP, American Hospital Association, American Red Cross, American Society for Transplantation and Cellular Therapy, American Society of Anesthesiologists, American Society of Clinical Pathologists, American Society of Hematology, Associa- tion of American Medical Colleges, Blood Centers of America, College of American Pathologists, Federation of American Hos- pitals, and Society for the Advancement of Patient Blood Management.
Healthcare on the move Amazon announced they are expanding their In-person care services to more than 20 new cities in 2022, which will bring more care options to Amazon Care’s growing customer base. Medline grew vendor partnerships in 2021 with more than 230 healthcare provid- ers and health systems worth nearly $2 billion in annual, incremental medical supplies and solution sales that span the continuum of care. Cook Medical Reproductive Health business will be acquired by CooperCompa- nies. It includes Cook’s Reproductive Health business within their MedSurg division.
Cardinal Health partners with Kinaxis to optimize digital supply chain planning. BD (Becton, Dickinson and Company), announced a collaboration with Return- Safe, an all-in-one software solution for COVID-19 employee health, safety and compliance, to integrate the BD Veritor At-Home COVID-19 Test directly within the ReturnSafe testing management platform.
DHL Supply Chain announced its Life Sci- ences and Healthcare (LSHC) sector is investing upwards of $400 million to expand its pharmaceutical and medical device distribution network with the goal of bringing critical healthcare products closer to trade partners and patients. Christiana Care Health System, Inc. and Prospect Medical Holdings, Inc. announced the signing of a Letter of Intent for Chris- tianaCare to acquire Crozer Health from Prospect. HPN
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
